BioMarin
Trade BioMarin 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BMRN
BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. 
BMRN Key Statistics
BMRN News
BioMarin (BMRN) Pharmaceutical announced that the U.S. FDA has accepted for Priority Review the company’s Palynziq supplemental Biologics License Application to...
Biomarin Pharmaceutical Inc. (BMRN) has disclosed a new risk, in the Corporate Activity and Growth category. Elevate Your Investing Strategy: Take advantage o...
Although the company recorded higher sales overall, it's decided to divest one of its products. BioMarin Pharmaceutical (BMRN +1.56%) reported its third-quarte...
Analyst ratings
82%
of 28 ratingsMore BMRN News
Investors in BioMarin Pharmaceutical Inc (Symbol: BMRN) saw new options begin trading today, for the July 2026 expiration. One of the key inputs that goes into...
Truist lowered the firm’s price target on BioMarin (BMRN) to $80 from $90 and keeps a Buy rating on the shares. The firm cites the company’s Q3 revenue miss as...
Wedbush analyst Yun Zhong reiterated a Buy rating on BioMarin Pharmaceutical today and set a price target of $94.00. Elevate Your Investing Strategy: Take advan...
Phil Nadeau, an analyst from TD Cowen, maintained the Buy rating on BioMarin Pharmaceutical. The associated price target remains the same with $120.00. Elevate...
Biomarin Pharmaceutical Inc. ((BMRN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium...
Biomarin Pharmaceutical Inc. ((BMRN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium...
Biomarin Pharmaceutical Inc. ((BMRN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium...